Search Results
1,650 results
Your search is now limited to «HIV/AIDS» expert search.
Lancet 04/25/2019 19:11
Guise echoes the Commission's finding that HIV exceptionalism has been extraordinarily effective, generating an unprecedented, multisectoral, and genuinely global movement that reduced new HIV infections and AIDS-related deaths and made incalculable contributions to the future health and wellbeing of communities and countries across the globe ...
More from Lancet:
BIOENGINEER.ORG 04/25/2019 15:25
The two studies published in Journal of Acquired Immune Deficiency Syndrome (JAIDS) were initiated in 2016 to address a public health emergency in London, Ontario when HIV rates amongst injection drug users more than doubled.
More from BIOENGINEER.ORG:
NaturalNews.com 04/25/2019 14:28
Natural News) Deliberately transmitting Human Immunodeficiency Virus (HIV) to other people without their knowledge was considered a misdemeanor offense rather than a felony in California which started on January 1, 2018, as reported by The Daily Mail.
More from NaturalNews.com:
AllAfrica News (Africa) 04/25/2019 10:32
Around 1 million people are living with HIV in Malawi, with new HIV infections in 2017 down by 40 percent since 2010, according to the UN agency.
More from AllAfrica News (Africa):
PR Newswire 04/25/2019 10:24
A major challenge to HIV-1 vaccine development has been a lack of understanding of how to direct the immune system down a very specific path towards protective antibody responses," Dr. Li explains.
More from PR Newswire:
FDLI SmartBrief 04/25/2019 10:05
The Department of Justice will review a 2015 government patent related to the use of Gilead Sciences' Truvada for the prevention of HIV infection, an indication approved by the FDA in 2012.
More from FDLI SmartBrief:
Kaiser Health News 04/25/2019 08:34
The move comes as AIDS activists have criticized the Centers for Disease Control and Prevention for failing to reach a deal with Gilead Sciences (GILD) over royalties on its sales of the Truvada pill.
More from Kaiser Health News:
As healthcare workers are able to spend less time treating HIV, TB, or malaria, they can devote more time to vaccination campaigns, prenatal care, or health education.
More from Elizabeth Glaser Pediatric AIDS Foundation Blog:
ClinicalTrials.gov 04/25/2019 07:40
... term goal for the proposed research is to apply a systems biology approach to discover evidence that provides the basis for understanding the complex and at times conflicting roles for marijuana in chronic inflammation in HIV-infected youth.
More from ClinicalTrials.gov:
ENDPOINTS 04/25/2019 07:16
Now attention has turned to its HIV pill, Truvada, which the CDC reportedly has some patents on.
More from ENDPOINTS:
Research Objectives and Scope Since the report of initial HIV cases back in early 1980’s, the face of HIV/AIDS has significantly changed from an acute and/or subacute fatal illness into a chronic, manageable illness due to the outstanding advances in HIV treatment.
More from National Institutes of Health (NIH):
Healio News 04/24/2019 11:45
Therefore, options for becoming pregnant while limiting HIV transmission should be offered and accessible to HIV-affected couples desiring children.
More from Healio News:
MedPageToday.com 04/24/2019 10:30
WASHINGTON -- Trump administration officials offered new details on their plan to end HIV/AIDS by 2030 during a panel discussion hosted by the Kaiser Family Foundation on Monday.
More from MedPageToday.com:
04/24/2019 08:28
TAMPA, Florida, April 24, 2019 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology biotechnology company focused on innovative treatments based on the Company's proprietary NK-engager (TriKE) platform and Multi-Target Bispecific Drug Conjugate (MTBDC) platform, announced today its Tri-Specific Killer Engager can target HIV infected cells in University of Minnesota's preclinical testing.
More from :
News-Medical.net 04/24/2019 06:09
Both molecules have potent late-replication effects that dramatically disrupt HIV particle organization and alter the distribution of morphology of the viral particles.
More from News-Medical.net:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications